blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3192874

EP3192874 - VIRUS PURIFICATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.08.2020
Database last updated on 02.08.2024
FormerThe patent has been granted
Status updated on  13.09.2019
FormerGrant of patent is intended
Status updated on  14.05.2019
FormerExamination is in progress
Status updated on  24.08.2018
FormerRequest for examination was made
Status updated on  01.12.2017
FormerThe application has been published
Status updated on  16.06.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Oxford BioMedica (UK) Limited
Windrush Court
Transport Way
Oxford, OX4 6LT / GB
[2017/29]
Inventor(s)01 / TRURAN, Richard
Oxford BioMedica (UK) Limited
Windrush Court
Transport Way
Oxford OX4 6LT / GB
02 / BUCKLEY, Robert
Oxford BioMedica (UK) Limited
Windrush Court
Transport Way
Oxford OX4 6LT / GB
03 / RADCLIFFE, Pippa
Oxford BioMedica (UK) Limited
Windrush Court
Transport Way
Oxford OX4 6LT / GB
04 / MISKIN, James
Oxford BioMedica (UK) Limited
Windrush Court
Transport Way
Oxford OX4 6LT / GB
05 / MITROPHANOUS, Kyri
Oxford BioMedica (UK) Limited
Windrush Court
Transport Way
Oxford OX4 6LT / GB
 [2017/29]
Representative(s)D Young & Co LLP
3 Noble Street
London EC2V 7BQ / GB
[N/P]
Former [2017/29]D Young & Co LLP
120 Holborn
London EC1N 2DY / GB
Application number, filing date16002644.918.06.2009
[2017/29]
Priority number, dateUS20080073685P18.06.2008         Original published format: US 73685 P
[2017/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3192874
Date:19.07.2017
Language:EN
[2017/29]
Type: B1 Patent specification 
No.:EP3192874
Date:16.10.2019
Language:EN
[2019/42]
Search report(s)(Supplementary) European search report - dispatched on:EP13.06.2017
ClassificationIPC:C12N15/867
[2017/29]
CPC:
C12N15/86 (EP,US); A61K48/0091 (EP,US); A61P1/00 (EP);
A61P1/02 (EP); A61P25/00 (EP); A61P27/00 (EP);
A61P27/02 (EP); A61P27/16 (EP); A61P35/00 (EP);
A61P37/06 (EP); A61P9/00 (EP); C12N7/00 (EP,US);
A61K48/00 (EP,US); C12N2740/15043 (EP,US); C12N2740/15051 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2018/01]
Former [2017/29]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:VIRUSREINIGUNG[2017/29]
English:VIRUS PURIFICATION[2017/29]
French:PURIFICATION DE VIRUS[2017/29]
Examination procedure13.12.2016Date on which the examining division has become responsible
19.10.2017Amendment by applicant (claims and/or description)
25.11.2017Examination requested  [2018/01]
27.08.2018Despatch of a communication from the examining division (Time limit: M04)
20.12.2018Reply to a communication from the examining division
15.05.2019Communication of intention to grant the patent
03.09.2019Fee for grant paid
03.09.2019Fee for publishing/printing paid
03.09.2019Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP09766124.3  / EP2307551
Opposition(s)17.07.2020No opposition filed within time limit [2020/39]
Fees paidRenewal fee
13.04.2017Renewal fee patent year 03
13.04.2017Renewal fee patent year 04
13.04.2017Renewal fee patent year 05
13.04.2017Renewal fee patent year 06
13.04.2017Renewal fee patent year 07
13.04.2017Renewal fee patent year 08
16.06.2017Renewal fee patent year 09
21.06.2018Renewal fee patent year 10
27.06.2019Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU18.06.2009
CY16.10.2019
CZ16.10.2019
EE16.10.2019
HR16.10.2019
LT16.10.2019
LV16.10.2019
MC16.10.2019
MK16.10.2019
MT16.10.2019
RO16.10.2019
SI16.10.2019
SK16.10.2019
BG16.01.2020
GR17.01.2020
IS16.02.2020
PT17.02.2020
LU18.06.2020
[2022/32]
Former [2022/28]HU18.06.2009
CY16.10.2019
CZ16.10.2019
EE16.10.2019
HR16.10.2019
LT16.10.2019
LV16.10.2019
MC16.10.2019
MT16.10.2019
RO16.10.2019
SI16.10.2019
SK16.10.2019
BG16.01.2020
GR17.01.2020
IS16.02.2020
PT17.02.2020
LU18.06.2020
Former [2021/15]CZ16.10.2019
EE16.10.2019
HR16.10.2019
LT16.10.2019
LV16.10.2019
MC16.10.2019
RO16.10.2019
SI16.10.2019
SK16.10.2019
BG16.01.2020
GR17.01.2020
IS16.02.2020
PT17.02.2020
LU18.06.2020
Former [2021/12]CZ16.10.2019
EE16.10.2019
HR16.10.2019
LT16.10.2019
LV16.10.2019
MC16.10.2019
RO16.10.2019
SI16.10.2019
SK16.10.2019
BG16.01.2020
GR17.01.2020
IS16.02.2020
PT17.02.2020
Former [2020/51]CZ16.10.2019
EE16.10.2019
HR16.10.2019
LT16.10.2019
LV16.10.2019
RO16.10.2019
SI16.10.2019
SK16.10.2019
BG16.01.2020
GR17.01.2020
IS16.02.2020
PT17.02.2020
Former [2020/37]CZ16.10.2019
EE16.10.2019
HR16.10.2019
LT16.10.2019
LV16.10.2019
RO16.10.2019
SK16.10.2019
BG16.01.2020
GR17.01.2020
IS16.02.2020
PT17.02.2020
Former [2020/36]CZ16.10.2019
EE16.10.2019
HR16.10.2019
LT16.10.2019
LV16.10.2019
RO16.10.2019
BG16.01.2020
GR17.01.2020
IS16.02.2020
PT17.02.2020
Former [2020/35]CZ16.10.2019
HR16.10.2019
LT16.10.2019
LV16.10.2019
RO16.10.2019
BG16.01.2020
GR17.01.2020
PT17.02.2020
IS24.02.2020
Former [2020/26]HR16.10.2019
LT16.10.2019
LV16.10.2019
BG16.01.2020
GR17.01.2020
PT17.02.2020
IS24.02.2020
Former [2020/24]LT16.10.2019
LV16.10.2019
BG16.01.2020
GR17.01.2020
PT17.02.2020
IS24.02.2020
Former [2020/22]LT16.10.2019
BG16.01.2020
PT17.02.2020
Documents cited:Search[A]  - ROHLL J B ET AL, "Design, production, safety, evaluation and clinical applications of nonprimate lentiviral vectors", METHODS IN ENZYMOLOGY, ACADEMIC PRESS INC, SAN DIEGO, CA, US, (20020101), vol. 346, ISSN 0076-6879, pages 466 - 500, XP009053525 [A] 1-16 * page 494, first paragraph; Protocol 1: Transient vector production; *

DOI:   http://dx.doi.org/10.1016/S0076-6879(02)46072-7
 [A]  - WONG L-F ET AL, "Transduction patterns of pseudotyped lentiviral vectors in the nervous system", MOLECULAR THERAPY, ACADEMIC PRESS, SAN DIEGO, CA, US, (20040101), vol. 9, no. 1, ISSN 1525-0016, pages 101 - 111, XP008053109 [A] 1-16 * materials and methods; *

DOI:   http://dx.doi.org/10.1016/j.ymthe.2003.09.017
 [A]  - WHITELAW C B A ET AL, "Efficient generation of transgenic pigs using equine infectious anaemia virus (EIAV) derived vector", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, (20040730), vol. 571, no. 1-3, ISSN 0014-5793, pages 233 - 236, XP004523343 [A] 1-16 * materials and methods; *

DOI:   http://dx.doi.org/10.1016/j.febslet.2004.06.076
by applicantEP0229866
 EP0445625
 WO9429440
 US5661023
 WO9805635
 WO9807859
 WO9809985
 WO9817815
 US5837520
 WO9915683
 WO9941397
 US5952199
 WO9961639
 EP0572401
 US6100071
 WO0052188
 US6261823
 WO0179518
 WO0229065
 WO03097797
 WO2004022761
 WO2005029065
 WO2007071994
 WO2007072056
    - LEWIS; EMERMAN, J. VITOL., (1993), vol. 68, page 510
    - BIENEMANN ET AL., MOL THA., (2003), vol. 5, page 588
    - YAMADA ET AL., BIOTECHNIQUES, (2003), vol. 34, no. 5, pages 1074 - 1078,1080
    - COFFIN ET AL., Retroviruses, COLD SPRING HARBOR LABORATORY PRESS, (1997), pages 758 - 763
    - YU ET AL., PROC. NATL. ACAD. SCI., (1986), vol. 83, pages 3194 - 3198
    - DOUGHERTY; TEMIN, PROC. NATL. ACAD. SCL, (1987), vol. 84, pages 1197 - 1201
    - HAWLEY ET AL., PROC. NAIL ACAD. SCL, (1987), vol. 84, pages 2406 - 2410
    - YEE ET AL., PROC. NATL. ACAD. SCI, (1987), vol. 91, pages 9564 - 9568
    - JOLLY ET AL., NUCLEIC ACIDS RES., (1983), vol. 11, pages 1855 - 1872
    - EMERMAN; TEMIN, CELL, (1984), vol. 39, pages 449 - 467
    - HERMAN; COFFIN, SCIENCE, (1987), vol. 236, pages 845 - 848
    - PARLEY ET AL., J. GEN. MED, (2007), vol. 9, pages 345 - 356
    - MOL. CELL. BIOL., vol. 5, pages 431 - 437
    - EMI ET AL., J. VIROL, (1991), vol. 65, pages 1202 - 1207
    - ABE ET AL., J. VIROL, (1998), vol. 72, no. 8, pages 6356 - 6361
    - BUMS ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 8033 - 8037
    - YEE ET AL., PROC. NATL ACAD. SCI. USA, (1994), vol. 91, pages 9564 - 9568
    - LIN, EMI ET AL., J. VIROL., (1991), vol. 65, pages 1202 - 1207
    - AKKINA ET AL., J. VIROL., (1996), vol. 70, pages 2581 - 5
    - KUMAR M; BRADOW BP; ZIMMERBERG J, HUM. GENE THER., (2003), vol. 14, no. 1, pages 67 - 77
    - ROSE ET AL., J. VIROL., (1982), vol. 43, pages 361 - 364
    - HANHAM ET AL., J. VIROL., (1993), vol. 67, pages 530 - 542
    - TUFFEREAU ET AL., J. VIROL., (1998), vol. 72, pages 1085 - 1091
    - KUCERA ET AL., J. VIROL, (1985), vol. 55, pages 158 - 162
    - DIETZSCHOLD ET AL., PNAS, (1983), vol. 80, pages 70 - 74
    - SEIF ET AL., J.VIROL, (1985), vol. 53, pages 926 - 934
    - COULON ET AL., J, VIROL., (1998), vol. 72, pages 273 - 278
    - TUFFEREAN ET AL., J. VIROL., (1998), vol. 72, pages 1085 - 10910
    - BURGER ET AL., J. GEN. VIROL, (1991), vol. 72, pages 359 - 367
    - GAUDIN ET AL., J. VIROL., (1995), vol. 69, pages 5528 - 5534
    - BENMANSOUR ET AL., J. VIROL, (1991), vol. 65, pages 4198 - 4203
    - LUO ET AL., MICROBIOL. IMMUNE!., (1998), vol. 42, pages 187 - 193
    - COLL, ARCH. VIROL., (1997), vol. 142, pages 2089 - 2097
    - LUO ET AL., VIRUS RES., (1997), vol. 51, pages 35 - 41
    - LUO ET AL., MICROBIOL. IMMUNOL., (1998), vol. 42, pages 187 - 193
    - COLL, ARCH, VIROL., (1995), vol. 140, pages 827 - 851
    - TUCHIYA ET AL., VIRUS RES., (1992), vol. 25, pages 1 - 13
    - MORIMOTO ET AL., VIROLOGY, (1992), vol. 189, pages 203 - 216
    - GAUDIN ET AL., VIROLOGY, (1992), vol. 187, pages 627 - 632
    - WHITTETAL, VIROLOGY, (1991), vol. 185, pages 681 - 688
    - DIETZSCHOLD ET AL., J. GEN. VIROL., (1978), vol. 40, pages 131 - 139
    - DIETZSCHOLD ET AL., DEV. BIOL. STAND., (1978), vol. 40, pages 45 - 55
    - DIETZSCHOLD ET AL., J. VIROL., (1977), vol. 23, pages 286 - 293
    - OTVOS ET AL., BIOCHIM. BIOPHYS. ACTA, (1994), vol. 1224, pages 68 - 76
    - DICKINS ET AL., NATURE GENETICS, (2005), vol. 37, pages 1289 - 1295
    - SILVA ET AL., NATURE GENETICS, (2005), vol. 37, pages 1281 - 1288
    - RALPH ET AL., NATURE MEDICINE, (2005), vol. 11, pages 429 - 433
    - "Pharmaceutical Process Filtration Catalogue", MILLlPORE catalogue, (1995), pages 177 - 202
    - RADCLIFFE ET AL., GENE THERAPY, (2008), vol. 15, pages 289 - 297
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.